Aurobindo Pharma, JSW Steel, Wipro, TCS, HCL Tech, LTIMindree among top stocks to track today

Stocks to watch today: Indian equity benchmarks Nifty 50 and Sensex are likely to start Thursday's session on a lower note amid mixed moves across global markets. GIFT Nifty futures — an early indicator of the Nifty 50 index — were down 4 points or 0.02 per cent at 19,561 ahead of the opening bell on Dalal Street.

Here's a list of stocks that may trade actively in today's session:

TCS: The IT bellwether, reported on Wednesday a consolidated net profit of Rs 11,074 crore for the quarter ended June 30, 2023 (Q1FY24). On a year-on-year (YoY) basis, the profit grew 16.8 per cent while on a QoQ basis, the profit declined 2.79 per cent. TCS also declared an interim dividend of Rs 9 per share. READ MORE

HCL Technologies reported on July 12 a consolidated net profit of Rs 3,534 crore for the quarter ended June 30, 2023 (Q1FY24). The company had posted a profit of Rs 3,983 crore in the previous quarter and Rs 3,283 crore in the year-ago period. On a sequential basis, the profit slipped by 11.2 per cent while on a year-on-year (YoY) basis, the figure grew by 7.6 per cent. Revenue from operations came in at Rs 26,296 crore, up 12 per cent YoY but down 1.16 per cent on a QoQ basis. READ MORE

Wipro: The IT services firm is slated to release its Q1 earnings today. 

Hindalco Industries Ltd: The company on July 12 said its board has approved a proposal to sell land situated at Maharashtra's Kalwa to Birla Estates for a sum of Rs 595 crore. According to an exchange filing by Hindalco, the definitive documents are to be signed in due course and the sale is expected to be completed within a period of 15 months.

Lupin: The company said that the US FDA inspected Lupin’s Nagpur oral solid dosage facility from July 3 to July 11, 2023. The inspection closed with the issuance of Form 483 with two observations.

Godrej Properties: The company announced that it has emerged as the highest bidder and has secured the Letter of Intent to develop two group housing plots. The two prime projects, spread over 2.76 acres and 5.15 acres, respectively, shall have a combined estimated revenue potential of approximately Rs 3,100 crore.

Aurobindo Pharma: The company announced that its wholly-owned subsidiary company, APL Healthcare Limited, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sevelamer Hydrochloride Tablets 400 mg and 800 mg, Sevelamer Hydrochloride Tablets 400 mg and 800 mg, to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Renagel Tablets, 400 mg and 800 mg, of Genzyme Corporation.

SpiceJet: SpiceJet promoter Ajay Singh has decided to infuse Rs 500 crore into SpiceJet by way of subscribing to fresh equity shares and/or convertible instruments. The infusion of fresh capital will substantially strengthen the company’s financial position and is a powerful vote of confidence in its future and long-term viability. It marks a pivotal moment in SpiceJet’s journey towards sustained growth and long-term success.

LTIMindtree, JSW: The company will enter the Nifty50 index today as HDFC shares have been delisted following the reverse merger between HDFC Bank and HDFC Ltd. On the BSE, JSW Steel will replace HDFC on the Sensex. 

Patanjali Foods: Patanjali Foods' promoter, Patanjali Ayurved Limited, launched an offer for sale to sell up to 7 per cent equity in Patanjali Foods. The company said 2.53 crore shares will be up for sale, for which the OFS floor price is Rs 1,000/share.